Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001821825-24-000105
Filing Date
2024-09-17
Accepted
2024-09-17 16:04:28
Documents
2
Period of Report
2024-09-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1726603459.html 3  
1 FORM 3 wk-form3_1726603459.xml 3 8408
2 EX-24 poakarp.txt EX-24 2946
  Complete submission text file 0001821825-24-000105.txt   12775
Mailing Address C/O ORGANON & CO., 30 HUDSON STREET FLOOR 33 JERSEY CITY NJ 07032
Business Address
Karp Daniel (Reporting) CIK: 0001744046 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40235 | Film No.: 241304235

Mailing Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302 551-430-6000
Organon & Co. (Issuer) CIK: 0001821825 (see all company filings)

EIN.: 464838035 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)